VENUS REMEDIES Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES Quarterly Results    (VSRM)

Here are the latest quarterly results of VENUS REMEDIES. For more details, see the VENUS REMEDIES financial fact sheet and VENUS REMEDIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

VENUS REMEDIES Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
3
Dec-18
3
Mar-19
3
Jun-19
3
Sep-19
8-Qtr Chart
Click to enlarge
Net Sales Rs m931932655809691864708801 
Other income Rs m1321253847 
Turnover Rs m933935657821695902712808 
Expenses Rs m754838554644643835607655 
Gross profit Rs m1779410116547-61102145 
Depreciation Rs m8962828383838383 
Interest Rs m849877919406049 
Profit before tax Rs m5-62-563-125-105-3720 
Tax Rs m0320-5-6-102 
Profit after tax Rs m5-94-568-119-104-3719 
Gross profit margin %19.010.115.520.46.9-7.014.418.2 
Effective tax rate %0.0-50.90.0-161.64.41.00.08.1 
Net profit margin %0.6-10.1-8.51.0-17.3-12.1-5.22.3 
Diluted EPS Rs 0.5 -8.2 -4.9 0.7 -10.4 -9.1 -3.2 1.6  
Diluted EPS (TTM) Rs 6.0 -6.1 -11.7 -11.9 -22.8 -23.7 -22.1 -21.1  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: VENUS REMEDIES 4QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   NEULAND LABS  IPCA LABS  DIVIS LABORATORIES  PFIZER  INDRAPRASTHA MEDICAL  

Compare VENUS REMEDIES With:   NEULAND LABS  IPCA LABS  DIVIS LABORATORIES  PFIZER  INDRAPRASTHA MEDICAL  

Compare VENUS REMEDIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 134 Points Lower; Finance and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure during closing hours today and ended marginally lower.

Views on news

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

VENUS REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of VENUS REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of VENUS REMEDIES. Also includes updates on the valuation of VENUS REMEDIES.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

I Recommended this Stock over Page Industries because it's Relevant to Doubling Your Income (Profit Hunter)

Sep 7, 2020

Things are not often what they seem in the market and how you can take advantage of this.

The NASDAQ Whale Could Harm Your Portfolio (Fast Profits Daily)

Sep 7, 2020

The discovery of Softbank pushing up prices on the NASDAQ will cause volatility in the market. Stay alert!

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

VENUS REMEDIES SHARE PRICE


Sep 18, 2020 (Close)

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES 5-YR ANALYSIS

COMPARE VENUS REMEDIES WITH

MARKET STATS